Xintongtai Granule: Investigating the serum pharmacology and mechanisms of action against atherosclerosis

Du, Lixin; Long, Hongping; Wei, Jiaming; Lu, Huiling; Xiao, Yifei; Li, Ya; Guo, Zhihua

doi:10.1016/j.jchromb.2024.124165

Journal of Chromatography B

2024

DOI: 10.1016/j.jchromb.2024.124165

|View full text |Cite

Xintongtai Granule: Investigating the serum pharmacology and mechanisms of action against atherosclerosis

Lixin Du,

Hongping Long,

Jiaming Wei

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Unveiling the therapeutic potential of airpotato yam rhizome against colorectal cancer: a network pharmacology approach

Xie,

Xu,

Chen

et al. 2024

Front. Oncol.

View full text Add to dashboard Cite

ObjectiveThe objective of this investigation was to elucidate the key active compounds and molecular mechanisms underlying the therapeutic potential of airpotato yam rhizome (AYR) in colorectal cancer (CRC) treatment.MethodsBy utilizing network pharmacology and molecular docking, key targets and signaling pathways of AYR against CRC were predicted and subsequently validated in cellular and mouse xenograft models.ResultsThis study initially predicted that quercetin was the primary compound in AYR that might have potential efficacy against CRC and that EGFR and AKT1 could be the main targets of AYR, with the EGF/EGFR-induced PI3K/AKT signaling pathway potentially playing a crucial role in the anti-CRC effects of AYR. Molecular docking analysis further indicated a strong binding affinity between quercetin and EGFR, primarily through hydrogen bonds. Additionally, the AYR-derived drug-containing serum was found to inhibit the PI3K/AKT signaling pathway, as demonstrated by decreased levels of p-PI3K, p-AKT, and BCL2, which ultimately led to enhanced apoptosis of HCT116 and HT29 cells. The potential antitumor effects of AYR were investigated in nude mouse xenograft models of human HCT116 and HT29 cells, in which AYR was found to induce tumor cell apoptosis and inhibit tumor formation.ConclusionAYR may promote CRC cell apoptosis by suppressing the PI3K/AKT signaling pathway, which provides a basis for further research on the safe and effective use of AYR for the treatment of CRC.

show abstract

Unveiling the therapeutic potential of airpotato yam rhizome against colorectal cancer: a network pharmacology approach

Xie,

Xu,

Chen

et al. 2024

Front. Oncol.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Xintongtai Granule: Investigating the serum pharmacology and mechanisms of action against atherosclerosis

Cited by 1 publication

References 35 publications

Unveiling the therapeutic potential of airpotato yam rhizome against colorectal cancer: a network pharmacology approach

Unveiling the therapeutic potential of airpotato yam rhizome against colorectal cancer: a network pharmacology approach

Contact Info

Product

Resources

About